Spermatozoa as biomarkers for the assessment of human male infertility and genotoxicity

Syst Biol Reprod Med. 2012 Feb;58(1):41-50. doi: 10.3109/19396368.2011.637152.

Abstract

Establishing specific biomarkers for the assessment of human male fertility status is an important goal to ensure the fitness of the male contribution so as to support the birth of a healthy child. Spermatozoa are considered an optimal surrogate tissue for the evaluation of spermatogenic function. Unlike the cells of the testis, spermatozoa do not require invasive procedures to procure a sample. A broad range of sperm biomarkers and tests have been described as useful for the assessment of the sperm function. However, these approaches appear limited considering the current state of the art of molecular diagnostics that could be developed for this purpose. In this review, we outline the suite of sperm biomarkers that are currently in use to assess human male fertility status. Their use as indicators of genotoxic exposure will be discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aneuploidy
  • Biomarkers / metabolism
  • Cell Shape
  • Cell Survival
  • Chromatin Assembly and Disassembly
  • DNA / metabolism
  • DNA Damage
  • Fertility* / drug effects
  • Fertility* / genetics
  • Humans
  • Infertility, Male / chemically induced
  • Infertility, Male / diagnosis*
  • Infertility, Male / genetics
  • Infertility, Male / pathology
  • Infertility, Male / physiopathology
  • Male
  • Mutagens / adverse effects
  • RNA / metabolism
  • Risk Assessment
  • Semen Analysis*
  • Sperm Count
  • Sperm Motility
  • Spermatogenesis* / drug effects
  • Spermatogenesis* / genetics
  • Spermatozoa / drug effects
  • Spermatozoa / metabolism
  • Spermatozoa / pathology*

Substances

  • Biomarkers
  • Mutagens
  • RNA
  • DNA